Kathleen N Moore Selected Research

Kathleen N Moore Research Topics

Disease

81	Neoplasms (Cancer) 03/2024 - 12/2010
80	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 02/2008
24	Ovarian Epithelial Carcinoma 01/2023 - 02/2008
19	Carcinoma (Carcinomatosis) 04/2024 - 02/2009
13	Endometrial Neoplasms (Endometrial Cancer) 12/2019 - 02/2009
11	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 05/2007
10	Disease Progression 10/2023 - 02/2008
10	Fallopian Tube Neoplasms 10/2022 - 09/2011
9	Fatigue 10/2023 - 09/2011
8	Neutropenia 01/2022 - 09/2011
6	Thrombocytopenia (Thrombopenia) 10/2023 - 09/2011
6	Anemia 10/2023 - 01/2018
5	Nausea 04/2024 - 12/2019
4	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2018
3	Genomic Instability 01/2023 - 10/2020
3	Exanthema (Rash) 03/2022 - 09/2011
3	Hypertension (High Blood Pressure) 01/2022 - 02/2016
3	Obesity 01/2018 - 04/2014
2	Vomiting 04/2024 - 01/2020
2	Diarrhea 10/2023 - 01/2020
2	Carcinosarcoma 01/2022 - 10/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
2	Triple Negative Breast Neoplasms 01/2021 - 08/2019
2	Leukopenia 01/2019 - 01/2018
2	Ileus 01/2018 - 08/2008
2	Neoplasm Metastasis (Metastasis) 12/2012 - 02/2009
1	Pain (Aches) 04/2024
1	Lymphoma (Lymphomas) 10/2023
1	Body Weight (Weight, Body) 01/2023

Drug/Important Bio-Agent (IBA)

47	PlatinumIBA 03/2024 - 08/2008
23	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 05/2007
23	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2023 - 03/2015
22	Bevacizumab (Avastin)FDA Link 03/2024 - 04/2013
19	Biomarkers (Surrogate Marker)IBA 10/2023 - 04/2014
18	Carboplatin (JM8)FDA LinkGeneric 03/2024 - 05/2007
17	olaparibIBA 10/2023 - 01/2015
15	Immunoconjugates (Immunoconjugate)IBA 03/2024 - 01/2016
12	mirvetuximab soravtansineIBA 03/2024 - 04/2017
11	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2023 - 03/2015
10	niraparibIBA 01/2023 - 01/2018
9	Folate Receptor 1IBA 03/2024 - 04/2017
8	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 05/2007
8	veliparibIBA 01/2023 - 03/2015
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 04/2014
4	liposomal doxorubicin (Doxil)FDA Link 12/2023 - 02/2016
4	Folic Acid (Vitamin M)FDA LinkGeneric 12/2023 - 08/2017
4	atezolizumabIBA 10/2023 - 01/2019
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 11/2018
4	Monoclonal AntibodiesIBA 01/2020 - 04/2017
4	Maytansine (Maitansine)IBA 01/2020 - 01/2016
3	pembrolizumabIBA 04/2024 - 08/2019
3	binimetinibIBA 10/2023 - 11/2018
3	Poly Adenosine Diphosphate RiboseIBA 01/2023 - 01/2018
3	1-dodecylpyridoxal (PLD)IBA 11/2021 - 02/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 08/2008
2	ElectrolytesIBA 04/2024 - 01/2019
2	Topotecan (Hycamtin)FDA LinkGeneric 12/2023 - 03/2015
2	Immunoglobulin IsotypesIBA 12/2023 - 06/2023
2	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2018
2	adavosertibIBA 07/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
2	AntigensIBA 01/2023 - 06/2019
2	navicixizumabIBA 10/2022 - 01/2019
2	NivolumabIBA 03/2022 - 11/2019
2	trametinibIBA 01/2022 - 12/2019
2	balstilimabIBA 11/2021 - 09/2021
2	prexasertibIBA 01/2021 - 01/2021
2	Cetuximab (Erbitux)FDA Link 01/2021 - 12/2012
2	TubulinIBA 01/2020 - 04/2017
2	Gemcitabine FDA Link 01/2020 - 04/2011
2	TabletsIBA 01/2019 - 01/2018
2	CreatinineIBA 09/2011 - 04/2009
1	epacadostatIBA 04/2024
1	AZD5153IBA 10/2023
1	Chemokine CCL8IBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	Chemokine CCL22IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2023
1	Vitamin D FDA LinkGeneric 01/2023
1	B7-H1 AntigenIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Prealbumin (Transthyretin)IBA 01/2023
1	delta proteinIBA 10/2022
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Ifosfamide FDA LinkGeneric 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022

Therapy/Procedure

54	Drug Therapy (Chemotherapy) 12/2023 - 02/2008
50	Therapeutics 03/2024 - 05/2007
7	Immunotherapy 01/2023 - 01/2018
7	Adjuvant Chemotherapy 01/2023 - 02/2009
6	Radiotherapy 10/2019 - 03/2009
5	Neoadjuvant Therapy 01/2022 - 01/2015
3	Cytoreduction Surgical Procedures 01/2023 - 08/2008
3	Laparotomy 01/2018 - 01/2017
2	Chemoradiotherapy 01/2023 - 01/2020
2	Hysterectomy 04/2019 - 01/2018
2	Lymph Node Excision (Lymph Node Dissection) 01/2017 - 03/2008
2	Precision Medicine 04/2016 - 01/2016
1	Retreatment 12/2022